|
|
|
|
Non-Hodgkin's Lymphoma
Patient Information from the National Cancer Institute: Non-Hodgkin's Lymphoma During Pregnancy
Autoimmune Disease Tied to Non-Hodgkin's Lymphoma Nov 1, 2005 Cancerpage.com, ...with autoimmune disorders such as rheumatoid arthritis and Sjogren's syndrome appear to be at greater risk of non-Hodgkin's lymphoma (NHL), researchers report ...
Hodgkin's vs. non-Hodgkin's lymphoma: What's the difference? Oct 28, 2005 MayoClinic.com Other types of lymphomas involve different cells and are referred to as non-Hodgkin's lymphoma. There are more than 30 different ...
WV firefighter praises legislation Nov 10, 2005 Vancouver North Shore Outlook, ...year-old boys. "The studies have shown that non-Hodgkin's lymphoma can be caused from firefighter duties.". After battling cancer ...
Tackling lymphoma Oct 29, 2005 Daily News Journal (subscription), ..."It was hard because I had to be on TV in the middle of chemo (therapy)," says Hoge, who was diagnosed with non-Hodgkin's lymphoma, a cancer of the lymphatic ...
Cancer drug trial results touted Nov 10, 2005 Seattle Post Intelligencer ...drug to treat non-Hodgkin's lymphoma prolongs the time before a patient's symptoms progress, the Seattle biopharmaceutical company reported Wednesday. ...
Dendreon CFO takes over manufacturing Nov 11, 2005 Seattle Post Intelligencer A Corixa employee for 10 years, she was a key executive in winning federal approval for Bexxar, a treatment for non-Hodgkin's lymphoma. ...
Firefighters see compensation changes Nov 12, 2005 Richmond Review, The cancers are primary site brain, bladder, kidney, colorectal and ureter cancer, primary non-Hodgkin's lymphoma and primary leukemia. ...
Lymph-node cancers are treatable Nov 1, 2005 Contra Costa Times, Q: Our family would like to know the differences among lymphoma, Hodgkin's disease and non-Hodgkin's lymphoma. A: Lymphoma is cancer ...
GPC Biotech Announces Clearance From German Regulatory Authority ... Nov 9, 2005 Market Wire (press release) ...it was estimated that more than 54,000 people in the US and about 64,000 people in the European Union were diagnosed with non-Hodgkin's lymphoma, the most ...
Phase III MabThera maintenance trial in lymphoma shows positive ... Oct 30, 2005 Medical News Today (press release), ...the European Organisation for Research and Treatment of Cancer (EORTC) that a phase III study[1] in relapsed indolent non-Hodgkin's lymphoma (NHL) evaluating ...
FDA Approves Arranon to Treat Rare Leukemia and Lymphoma Nov 7, 2005 AXcess News, T-ALL. Lymphoblastic lymphoma (LBL) represents approximately 30% of childhood and 3% of adult non-Hodgkin's lymphoma (NHL). An estimated ...
Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Nov 1, 2005 Yahoo! News (press release) In June 2005, we reported the interim results of a Phase 2 study of this drug in patients with advanced non-Hodgkin's lymphoma, and we anticipate presentation ...
Review: Drinking-Water Nitrate and Health Nov 6, 2005 Food Consumer, In Slovakia, incidence of non-Hodgkin lymphoma (NHL) and colon cancer was significantly elevated among men and women exposed to public supply nitrate levels of ...
Allos Therapeutics Reports Third Quarter 2005 Financial Results Nov 10, 2005 PR Newswire (press release), ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ...
Why We Can't Prevent Cancer Nov 4, 2005 CounterPunch, ...by 690%, female lung & bronchial cancer increased by 685%, prostate cancer by 286%, myeloma by 273%, thyroid cancer by 258%, non-Hodgkin's lymphoma by 249 ...
THIRD ACCIDENTAL DEATH AT KAISER PERMANENTE Nov 9, 2005 CBS 5, ...wrong medication. Christopher Wibeto, who was diagnosed with non-Hodgkin's lymphoma, was given the wrong chemotherapy drug on Aug. 26 ...
Genitope Corporation Announces Financial Results for Third Quarter ... Nov 8, 2005 PR Newswire (press release), ...of our lead product candidate, MyVax(R) Personalized Immunotherapy, in patients with previously untreated follicular non-Hodgkin's lymphoma, is progressing as ...
Cancer patients get new drug before appraisal Nov 11, 2005 Yorkshire Post Today, ...system. Evidence suggests the drug will double the re-mission time of patients diagnosed with follicular non-Hodgkin's lymphoma. ...
British Columbia Recognizes Cancer as an Occupational Hazard for ... Nov 10, 2005 Homeland Response, The types of cancer are primary site brain cancer, primary site bladder cancer, primary site kidney cancer, primary non-Hodgkin's lymphoma, primary site ureter ...
Millennium Announces Clinical Updates at Analyst Day Meeting Nov 2, 2005 PR Newswire (press release), Non-Hodgkin's Lymphoma The Company announced today its intention to file a supplemental New Drug Application (sNDA) for VELCADE in mantle cell lymphoma in the ...
Cell hits treatment goals, but stock is sold Nov 11, 2005 Seattle Times, Cell Therapeutics said it hit its treatment goals in a trial of pixantrone in patients with relapsed non-Hodgkin's lymphoma, but investors sold off the Seattle ...
Legendary Bearcat Cook dies Nov 9, 2005 Cullman Times Online, St. Bernard Preparatory School. Cook coached the defense for the Saints, even though he was battling non-Hodgkin's lymphoma. "He ...
CAROL CAIN / MACOMB: Not even illness could stop salon owner Nov 10, 2005 Detroit Free Press, ...malaise a second thought. Ten years ago, Pniewski was diagnosed with non-Hodgkin's lymphoma. She underwent surgery, chemotherapy ...
Officer, mother does it all Nov 10, 2005 Asbury Park Press, ...the Manchester Little League field organizing a charity baseball game to raise money to help Derek Biederstadt, a local 14-year-old with non-Hodgkin's lymphoma ...
Viral links spur the search for cancer vaccines Nov 1, 2005 The Financial Express, Current trials for therapeutic vaccines are targeting melanoma, kidney, lung and breast cancers, Hodgkin's and Non-Hodgkin's lymphoma, the NCI says. ...
FDA grants fast review to lymphoma drug Oct 25, 2005 United Press International ...of the new therapy for previously untreated patients with intermediate grade or aggressive, CD20-positive, B cell non-Hodgkin's lymphoma, in combination with ...
Favrille to Expand Existing Facility to Support Commercial ... Nov 7, 2005 PR Newswire (press release), ...of FavId(R), the Company's lead product candidate currently in a Phase 3 clinical trial for the treatment of follicular B-cell non-Hodgkin's lymphoma (NHL). ...
FDA Grants Priority Review for Rituxan(R) Supplemental Biologics ... Oct 25, 2005 PR Newswire (press release), R) (Rituximab) in previously-untreated (front-line) patients with intermediate grade or aggressive, CD20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in ...
Yttrium 90 Ibritumomab Tiuxetan (Zevalin) as Effective in Older as ... Oct 24, 2005 DG News ...that use of the radioimmunotherapy agent yttrium 90 ibritumomab tiuxetan (Zevalin) is at least as effective in treating non-Hodgkin's lymphoma in patients over ...
Millennium Announces Clinical Updates at Analyst Day Meeting Nov 2, 2005 Yahoo! News (press release) Management also announced completed enrollment of 81 patients in a phase II study of VELCADE in relapsed follicular lymphoma, a type of Non-Hodgkin's lymphoma. ...
UK's CAT buys cancer drug candidates from Danisco Nov 1, 2005 ABC News Phase II clinical trials for hairy cell leukemia (HCL), and GCR-8015, a preclinical treatment for cancers including non-Hodgkin's lymphoma, from Danisco's ...
Structure of the Hematological Cancer Market and Its Perspectives Nov 3, 2005 Business Wire (press release), ...at a multitude of small oncology companies for leukemias and myelodysplastic syndromes, lymphomas (Hodgkin's disease, non-Hodgkin's lymphoma, mantle cell ...
FDA eyes wider use of Rituxan Oct 26, 2005 Inside Bay Area, ...whether Rituxan should be used with chemotherapy as a first treatment for patients with intermediate or aggressive non-Hodgkin's lymphoma, the companies said. ...
AnorMED reports fiscal 2006 second quarter results, and progress ... Nov 8, 2005 PR Newswire (press release), To date, 98 non-Hodgkin's lymphoma (NHL) patients and 100 multiple myeloma (MM) patients have entered into the Phase III trials. ...
Richard E. Smalley, RIP Oct 29, 2005 Scientific American E. Smalley, one of the co-discoverers of "buckyballs" and other fullerenes, died on Friday after years of intermittent struggle with non-Hodgkin's lymphoma. ...
FDA grants speedy review to Biogen, Genentech drug Oct 31, 2005 Reuters ...(DNA.N: Quote, Profile, Research) on Monday said US regulators would review on a priority basis their application to sell a non-Hodgkin's lymphoma drug they co ...
Local investors back Accentia IPO Nov 7, 2005 MSNBC Accentia's second potential blockbuster is Biovaxid, an injectable vaccine for the treatment of follicular non-Hodgkin's lymphoma (NHL). ...
Versatile Rituxan gets arthritis review Nov 1, 2005 Inside Bay Area, ...and Biogen Idec Inc.'s Rituxan, a cancer drug being considered for wider use against non-Hodgkin's lymphoma, has also won priority review as a treatment for ...
Obesity linked with leukemia Nov 4, 2005 Melbourne Herald Sun, ...was influenced by body size, the risk of multiple myeloma, lymphocytic leukemia, hairy cell leukemia, Hodgkin's lymphoma and non-Hodgkin's lymphoma were not. ...
PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & ... Nov 7, 2005 Genetic Engineering News, PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for non-Hodgkin's lymphoma and solid tumors, as well as an innovative drug discovery ...
A Cancer Win Not All Firefighters Share Nov 9, 2005 TheTyee.ca, ...passed legislation forcing the WCB to recognize seven kinds of cancer (brain cancer, bladder cancer, kidney cancer, non-Hodgkin's lymphoma, ureter, leukemia ...
FIREFIGHTERS: Compensation Volunteers excluded Nov 8, 2005 Williams Lake Tribune, These are: primary site brain cancer, primary site bladder cancer, primary site kidney cancer, primary non-Hodgkin's lymphoma, primary site ureter cancer ...
Wife: please help ease my husband's suffering Nov 9, 2005 Bexley Times, The 34-year-old's plea comes four years after her husband Somir, 44, was diagnosed with non-Hodgkin's Lymphoma, a cancer of the muscle tissue. ...
Cancer vaccine Nov 8, 2005 WHDH-TV, ...customized vaccines. Tom Berthold was diagnosed in 1996 with non-Hodgkin's lymphoma… a cancer of the immune system. He underwent ...
Genentech/Biogen cancer drug granted priority review by FDA Oct 27, 2005 Pharmaceutical Business Review ...review to the license application submitted by Genentech and Biogen Idec for Rituxan as an adjunctive treatment for patients with non-Hodgkin's lymphoma. ...
BioCryst to Present at the Rodman & Renshaw Techvest 7th Annual ... Nov 2, 2005 Yahoo! News (press release) Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...
... Go to the Article Oct 14, 2005 CancerWise ...rituximab (Rituxan®). Rituximab is a monoclonal antibody drug federally approved for use in non-Hodgkin's lymphoma. Monoclonal ...
Richard E. Smalley, RIP Oct 30, 2005 LaSalute.net, E. Smalley, one of the co-discoverers of "buckyballs" and other fullerenes, died on Friday after years of intermittent struggle with non-Hodgkin's lymphoma... ...
Biogen Idec and Genentech Announce FDA Acceptance of Supplemental ... Oct 31, 2005 PR Newswire (press release), ...received FDA approval in November 1997 for the treatment of relapsed or refractory low-grade or follicular, CD20-positive, B-cell, non-Hodgkin's lymphoma (NHL ...
Favrille Reports Third Quarter 2005 Financial Results Nov 2, 2005 PR Newswire (press release), ...product candidate, FavId(R), is nearing completion of patient enrollment in a pivotal Phase 3 clinical trial for follicular B-cell non-Hodgkin's lymphoma (NHL ...
Walk aids lymphoma research Oct 19, 2005 Augusta Chronicle (subscription), 2000. As with many cases of her type of indolent non-Hodgkin lymphoma, her swollen lymph nodes and fatigue didn't seem like cancer. ...
UPDATE 1-Genentech says FDA gives Rituxan priority review Oct 25, 2005 Reuters ...said their cancer drug Rituxan will get a speedy review from US regulators for the treatment of aggressive, but previously untreated non-Hodgkin's lymphoma. ...
Biogen warns of drug's dangers Oct 29, 2005 San Diego Union Tribune, Biogen Idec warned that one of its drugs to treat non-Hodgkin's lymphoma, Zevalin, can cause severe and sometimes fatal skin reactions. ...
Childhood cancer survivors face limitations Oct 31, 2005 Reuters.uk, The cancers included primary brain cancer, leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, kidney tumor, neuroblastoma, soft-tissue sarcoma or malignant ...
Reduced Radiation Dose May Be Effective for Early Hodgkin’s Oct 19, 2005 Cancer Consultants (press release), ...which fight infection. Lymphomas are divided into two types: non-Hodgkin's lymphoma and Hodgkin’s lymphoma. Hodgkin’s lymphoma ...
GlaxoSmithKline Announces Approval of ARRANON(R) (nelarabine) ... Oct 29, 2005 Biotech Intelligence (press release), Lymphoblastic lymphoma (LBL) is a type of non-Hodgkin's lymphoma (NHL), a cancer of the lymphatic system, which occurs more often in children than adults. ...
Roche says Phase III trial of cancer drug MabThera yields positive ... Oct 25, 2005 Forbes ...on trial by the European Organisation for Research and Treatment of Cancer as a treatment in so-called 'relapsed indolent non-Hodgkin's lymphoma' (NHL), is ...
Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005 Yahoo! News (press release) ...will expand its role in clinical research and development and funding of SB-743921 for the indications of non-Hodgkin's lymphoma, Hodgkin's lymphoma and ...
Infections eyed as cancer cause Oct 25, 2005 Vancouver Sun (subscription), Eighty per cent of gastric cancers are associated with the helicobacter pylori bacteria, while 20 per cent of cases of non- Hodgkin's lymphoma and Hodgkin's ...
Innovative Drug Tarceva Now Available in Europe to Tackle Growing ... Oct 30, 2005 Antara, Herceptin, and Xeloda in advanced-stage breast cancer, Herceptin in early-stage HER2-positive breast cancer, MabThera in non-Hodgkin's lymphoma, Avastin and ...
Pharma, biotech, post mixed finances. Oct 31, 2005 in-PharmaTechnologist, ...to $215.1 million. Sales of Rituxan for non-Hodgkin's lymphoma rose 16 per cent to $456.2 million for the quarter. Sales were boosted ...
Free Press / Flagstar Bank Marathon Oct 20, 2005 Detroit Free Press, ...exercise. But when the non-Hodgkin's lymphoma of her son-in-law, Dean Franco, worsened this spring, Bower was inspired to take a stand. ...
Cambridge Antibody Technology Acquires Oncology Product Candidates ... Oct 31, 2005 Yahoo! News (press release) ...an optimized version of GCR-3888, is in pre-clinical development as a potential treatment for B-cell malignancies including non-Hodgkin's lymphoma (NHL) and ...
New Survey Shows Cancer Patients Continue to Suffer From Extreme ... Oct 31, 2005 PR Newswire UK (press release), ...solid tumours receiving chemotherapy and treatment of symptomatic anaemia in adult patients with multiple myeloma, low-grade non-Hodgkin's lymphoma or chronic ...
Biogen revises warning label for cancer drug Oct 29, 2005 Boston Globe, ...after treatment. Zevalin is administered in conjunction with Biogen Idec's Rituxan for non-Hodgkin's lymphoma. Because potentially ...
`Terrible error,' then a death Nov 3, 2005 San Jose Mercury News, He said that even when he was in a Stanford hospital bed waiting to die, not from the non-Hodgkin's lymphoma with which he had been diagnosed, but from what ...
New drug guidance plans announced Nov 3, 2005 Daily Mail - UK, ...be docetaxel (Taxotere), paclitaxel (Taxol) and trastuzumab (Herceptin), all for breast cancer, rituximab (Mabthera) for non-Hodgkin's lymphoma, and bortezomib ...
CAT buys part of Genencor's Health Care ops from Danisco for 14 ... Nov 1, 2005 Forbes ...an optimised version of GCR-3888, is in pre-clinical development as a potential treatment for B-cell malignancies including non-Hodgkin's lymphoma (NHL) and ...
Cancer patients hail speedier NHS checks on life-saving drugs Nov 3, 2005 Guardian Unlimited, The first five drugs to undergo the new process will be Herceptin, Taxol, another breast cancer drug, MabThera, for non-Hodgkin's lymphoma, and Velcade for ...
FDA to speed ruling on uses of Biogen cancer drug Oct 26, 2005 Boston Globe, Drug Administration will give speedy review to Biogen Idec Inc.'s request that Rituxan, its treatment for a specific type of non-Hodgkin's lymphoma, be used to ...
Teacher built Farmington school district's ESL program Oct 29, 2005 Pioneer Press, ...come.". Cobb, who was also an active member of Chapel Hill Church in Eagan, died Monday of non-Hodgkin's lymphoma. She was 59. The ...
Genitope Corporation to Present at Rodman and Renshaw Techvest 7th ... Nov 2, 2005 PR Newswire (press release), ...is conducting a pivotal phase 3 clinical trial using MyVax (R) Personalized Immunotherapy in previously untreated follicular non-Hodgkin's lymphoma patients. ...
Cougar Biotechnology Announces Presentation at Rodman & Renshaw ... Nov 2, 2005 Genetic Engineering News, ...which has completed Phase I clinical trials in prostate cancer, CB3304, which is currently being tested in a Phase I trial in non-Hodgkin's lymphoma and CB1089 ...
FURY AT 'FAST DRUGS' MOVE Nov 4, 2005 Mirror.co.uk, ...new drugs will be reviewed quickly in the first wave - breast cancer treatments Herceptin, Taxotere and Taxol, MabThera for non-Hodgkin's lymphoma and Velcade ...
Biogen marks key milestones in Rituxan tests Oct 31, 2005 Boston Business Journal, ...after the company's late August filing. Rituxan is already approved to treat non-Hodgkin's lymphoma. But Biogen Idec is exploring ...
Genentech, Biogen push biotech stocks higher Oct 31, 2005 Investor's Business Daily (subscription) Rituxan is already approved to treat non-Hodgkin's lymphoma. See full story. Biogen shares advanced 6% to $40.63, while Genentech gained 3% to $90.60. ...
Biogen, Genentech gain on Rituxan drug news Oct 31, 2005 Investor's Business Daily (subscription) ...end of February, they said. Rituxan is already approved for the treatment of non-Hodgkin's lymphoma. The companies are seeking to ...
Cancer-fighting drug warning level raised Oct 31, 2005 United Press International The drug already had a warning on its label. Zevalin is used with the cancer drug Rituxan when no other treatments of non-Hodgkin's lymphoma work. ...
FDA and Biogen Idec Issue Drug Safety Alert Concerning Fatal ... Oct 30, 2005 Newsinferno.com, ...is indicated for the treatment of patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (NHL), including ...
Spectrum Pharmaceuticals Reports Third Quarter 2005 Financial and ... Nov 4, 2005 PR Newswire (press release), Elsamitrucin * A multicenter, Phase 2 clinical trial in refractory non-Hodgkin's lymphoma, especially in Rituxan(R) failures, is running at approximately 30 ...
Roche: MabThera maintains its momentum Oct 28, 2005 Pharmaceutical Business Review 28 Oct 2005, 16:56 GMT - Roche has announced positive results from a phase III study evaluating MabThera as maintenance treatment in non-Hodgkin's lymphoma. ...
AnorMED to Seek Conditional Marketing Authorization in Europe for ... Oct 18, 2005 CNW Telbec (Communiqués de presse), These studies are ongoing in major transplant centers in the US One study is enrolling 300 non-Hodgkin's lymphoma (NHL) patients and the other study 300 ...
Novacea Announces Plans to Begin Phase 3 Clinical Study of DN-101 ... Nov 1, 2005 PR Newswire UK (press release), Banoxantrone, or AQ4N, is in a Phase 1 study in advanced malignancies and a Phase 1/2 study in patients with non-Hodgkin's lymphoma or chronic lymphocytic ...
Biotech Has October Blues Nov 1, 2005 PR Newswire (press release), ...oncology indications. Accentia's Biovaxid autologous cancer vaccine is in Phase III testing to treat non-Hodgkin's lymphoma. The ...
MUM'S GRIEF A AFTER SON DIES IN HER ARMS: ROSS GAVE US STRENGTH TO ... Oct 20, 2005 Glasgow Daily Record, And after blood tests, medics broke the news that he had non-Hodgkin's Lymphoma - a cancer which attacks the body's immune system. ...
Blogging for health Nov 1, 2005 Standard-Speaker, Perry was diagnosed in February with non-Hodgkin's lymphoma, when doctors found a malignant growth on his tongue. After surgery, came chemotherapy. ...
Swarthout leaves a legacy Oct 29, 2005 The Olympian, Swarthout, who coached the football team at Capital High School from 1976 to 1985, died Oct. 1 after an extended battle with non-Hodgkin's lymphoma. ...
ProNAi Therapeutics Raises $4.25m to Develop a New Class of ... Oct 19, 2005 Market Wire (press release) ProNAi has six product candidates that have the potential to treat multiple cancers, including non-Hodgkin's lymphoma, prostate, breast, and colon cancers. ...
Alcohol and drug addictions: Doctors, nurses are human, too Oct 31, 2005 Amarillo.com (subscription), He said was chemical-free for about six or seven years, but at age 40 he was diagnosed with non-Hodgkin's lymphoma and underwent a variety of procedures ...
Doctors trying continuous, low doses of chemo as new weapon ... Oct 31, 2005 Birmingham News, Doctors are reporting promising results in a handful of clinical trials on cancers that include brain tumors, non-Hodgkin's lymphoma, and breast and ovarian ...
?????????? Oct 30, 2005 ??c????, ...to help Genentech, a California biotech, produce Herceptin, a gene-targeted treatment for breast cancer, and Rituxan, a treatment for non-Hodgkin's lymphoma. ...
Province gives nod to firefighting perils Nov 4, 2005 Kamloops This Week, A plethora of deadly cancers is covered by the amendment, including primary site brain cancer, primary site kidney cancer, and primary non-Hodgkin's lymphoma. ...
Study Suggests Drycleaning Chemical Not a Risk Factor for Cancer Nov 4, 2005 U.S. Newswire (press release), ...primarily from the United States, had indicated that PERC exposure might increase the risk of esophageal and cervical cancer and of non-Hodgkin's lymphoma (NHL ...
Local family planning cancer benefit auction Oct 15, 2005 Freeport Journal Standard, He has been in and out of the hospital for treatments since being diagnosed with Burkitt's lymphoma, a type of non-Hodgkin's lymphoma, in July 2004. ...
Genentech, Biogen granted priority review by US FDA for sBLA to ... Oct 25, 2005 Forbes The sBLA concerns previously untreated patients with intermediate grade or aggressive, CD20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in combination with ...
Heartfelt gratitude 10 Sep 2005 Kimberly, of Cobram on the Murray River, was diagnosed with non-Hodgkin's lymphoma last year with a cancerous tumour engulfing her heart. ... Advertiser Adelaide,
Drug offers hope for non-Hodgkin's lymphoma Sep 9, 2005 ...radioactive "smart bombs" directly to cancer cells is showing great promise in treating patients with some types of non-Hodgkin's lymphoma, Canadian doctors say ... CTV.ca,
Bone marrow drive can help dentist, other African Americans Sep 8, 2005 ...in need. The 51-year-old African American dentist was diagnosed with non-Hodgkin's lymphoma and multiple myeloma in 2002. After ... Chicago Defender,
AnorMED Release: Medical journal, Blood, reports new stem cell ... Sep 6, 2005 ...transplantation. The Phase II study included 25 patients, 10 patients with multiple myeloma and 15 patients with non-Hodgkin's lymphoma. ... Hype & Hope,
Biogen Idec Cuts 17% of Jobs Sep 8, 2005 The Cambridge, Mass., company's new strategy will lead it to focus on the multiple sclerosis treatment Avonex and the non-Hodgkin's lymphoma drug Rituxan. ... TheStreet.com
BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... Sep 7, 2005 Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ... Yahoo! News (press release)
Alcohol intake lowers non-Hodgkin's risk Aug 16, 2005 People who drink alcohol have a lower risk of non-Hodgkin's lymphoma (NHL) than non-drinkers, researchers at Yale's Department of Epidemiology and Public ... myDNA.com,
Simple test provided cancer patient hope Sep 5, 2005 Yaffe entered the MD Anderson Cancer Clinic in Houston in a last-ditch effort to destroy the blood cancer called non-Hodgkin's lymphoma. ... Sun-Sentinel.com,
Allos Therapeutics to Present at the Bear Stearns Healthcare ... Sep 7, 2005 ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ... PR Newswire (press release),
Immunodiagnostics Shape Immunotherapeutics for Improved Cancer ... Aug 24, 2005 ...ibritumomab tiuxetan in a stem cell transplantation-conditioning regimen is relatively safe and may improve outcome in severe refractory non-Hodgkin's lymphoma ... Medscape (subscription)
The San Francisco 49ers and Novacea Join Forces to Tackle Prostate ... Sep 6, 2005 Banoxantrone, or AQ4N, is in a Phase 1 study in advanced malignancies and a Phase 1/2 study in patients with non-Hodgkin's lymphoma or chronic lymphocytic ... PR Newswire (press release),
David L. Jones Sep 6, 2005 ...in the Hanna Building until 1997, when he moved the organization to his home in Willoughby Hills after he was diagnosed with non-Hodgkin's Lymphoma which he ... News-Herald.com,
David L. Jones, started ad agency Sep 8, 2005 ...advertising and graphic arts agency 30 years ago and built it into a firm with clients across the country, died of complications of non-Hodgkin's lymphoma Sept ... Cleveland Plain Dealer,
Immune system finding paves way for vaccine use in some leukemia ... Aug 27, 2005 ...immunological effects of B-cell depletion and to assess the use of idiotype vaccine in mantle cell lymphoma, a rare type of non-Hodgkin's lymphoma for which ... I-Newswire.com (press release)
New therapy boosts lymphoma survival Aug 25, 2005 People with the most common type of non-Hodgkin's lymphoma, a cancer of the lymphatic tissue, can significantly boost their survival chances if they get a new ... Macleans,
Health Alert: Lymphoma Aug 16, 2005 In the case of Budd Severino, a tumor that formed near his spine proved to be a cancer of the lymph system called Non-Hodgkin's Lymphoma. ... WIS,
"A family is forever changed' Aug 27, 2005 The Welches first become involved in the walk after Janey Welch was diagnosed with stage IV of non-Hodgkin's lymphoma three years ago. She's in remission. ... Savannah Morning News,
Bike boy, 5, crushed to death by pillar Sep 6, 2005 The work of the Calendar Girls is dedicated to the memory of Matthew's father, John Baker, who died from non-Hodgkin's lymphoma in July 1998 aged 54. ... Leeds Today,
Filing Based on Data From Three Phase III Trials in More than ... Aug 17, 2005 R) (Rituximab), in previously untreated (front-line) patients with intermediate grade or aggressive, CD-20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in ... PharmaLive.com (press release),
Charity gets a cool new look; teammate steps up for friend Aug 25, 2005 ...team captain Don Parsons in 2002 after finding out that his infant daughter had been born severely deaf and his father was battling non-Hodgkin's lymphoma. ... OurSports Central (press release),
Doctor Admits to Fraud, Drug Counts Sep 2, 2005 ...on others. Plans for a second trial were complicated last year when Knox suffered a relapse of non-Hodgkin's lymphoma. A federal ... Los Angeles Times,
INEX Releases 2004 Operating Results & 2005 Milestones -- 17 Mar 2005 ...by the FDA that Marqibo was "not approvable" under the accelerated approval process as a treatment for relapsed aggressive non-Hodgkin's lymphoma (NHL) based ... / Canada NewsWire (press release),
Memorial for Sermeno is Saturday -- 17 Mar 2005 Lion Hotel. Sermeno, an employee who had suffered from non-Hodgkin's lymphoma, died Friday afternoon at a Portland hospital. The ... / Coos Bay World,
Northlanders go bald for cancer research funding -- 17 Mar 2005 Baldrick's event for three years. Her son Foster Patton, 11, Plaza Middle School sixth-grader, battled and beat Non-Hodgkin's lymphoma at the age of 7. ... / Gladstone Sun News,
PRAECIS PHARMACEUTICALS INCORPORATED Announces Issuance of Final ... -- 17 Mar 2005 PRAECIS also has an innovative development pipeline, including clinical programs in Alzheimer's disease, non-Hodgkin's lymphoma, and androgen-independent ... / Business Wire (press release),
Sprott personifies the spirit of Relay -- 17 Mar 2005 ...said. It was Non-Hodgkin's Lymphoma, which is not hereditary, not caused by smoking or drinking or any of the standard suspects. ... / Lincoln City News Guard,
Bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma -- Mar 12, 2005 Cancer Center, Houston, evaluated efficacy and toxicity of Bortezomib ( Velcade ) in 60 patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. ... / Xagena.it,
AIDS cocktails prevent cancer, study finds -- Mar 15, 2005 ...the records of more than 7,300 Swiss HIV patients and found those on HAART had lower risks of Kaposi's sarcoma and non-Hodgkin's lymphoma compared with those ... / Reuters AlertNet,
Q&A: Non-Hodgkin’s Lymphoma -- Mar 3, 2005 Non-Hodgkin's lymphoma (NHL) is the fifth most common form of cancer in the United States, and is made up of more than 20 types. ... / CancerWise
Human Genome Sciences Completes Patient Enrollment in a Phase 2 ... -- Mar 3, 2005 ...that it has completed the enrollment and initial dosing of patients in a Phase 2 clinical trial of HGS-ETR1 (mapatumumab) in advanced non-Hodgkin's lymphoma. ... / Yahoo News (press release)
Favrille, Inc. Reports Fourth Quarter and Year End 2004 Financial ... -- Mar 14, 2005 Assessment for and initiated our pivotal Phase III clinical trial testing FavId following Rituxan® in patients with follicular B-cell non-Hodgkin's lymphoma. ... / Yahoo News (press release)
Hepatitis C Infection Increases Risk of Lymphoma and Multiple ... -- Mar 14, 2005 ...that fight infection. Lymphomas are divided into two types, non-Hodgkin's lymphoma and Hodgkin’s lymphoma. Hodgkin’s lymphoma ... / Cancer Consultants (press release),
Spectrum Pharmaceuticals Reports 2004 Financial Results and ... -- Mar 15, 2005 Elsamitrucin * We are continuing to enroll patients in the Phase 2 trial of elsamitrucin in refractory non-Hodgkin's lymphoma, and expect completion of ... / PR Newswire (press release)
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... -- Mar 15, 2005 ...hydrochloride has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ... / PR Newswire (press release)
Millennium Announces Senior Executive Appointments --Expands Key ... -- Mar 14, 2005 For more than 15 years he has been an academic investigator conducting numerous clinical trials for patients with non-Hodgkin's lymphoma and other hematologic ... / PR Newswire (press release)
Eight-year-old pens 'My Dad Has Cancer' -- Mar 9, 2005 ...two sons. Most doctors' offices they visited didn't have books for children about Hodgkin's and Non-Hodgkin's Lymphoma. Coming up ... / Narragansett Times,
Hepatitis C Ups Lymphoma, Bone Marrow Cancer -- Feb 23, 2005 Feb. 23, 2005 - Hepatitis C infection ups a person's risk of non-Hodgkin's lymphoma and multiple myeloma, a Swedish study suggests. ... / WebMD
New Milford Hospital begins use of new cancer drugs -- Feb 28, 2005 ...to use Bexxar and Zevalin.The two drugs are capable of directly attacking one of the most common forms of non-Hodgkin's lymphoma — follicular lymphoma — as ... / Danbury News Times,
Hodgkin's Disease -- Feb 16, 2005 It can easily be confused with non-Hodgkin's lymphoma. ... There is a 3% risk, however, that LPDH will transform to non-Hodgkin's lymphoma. ... / philadelphia.about.com,
Association noted between certain non-liver cancers and hepatitis ... -- Feb 23, 2005 In Sweden, a cluster of four cases of non-Hodgkin's lymphoma in 554 HCV patients raised the question of an association between those two diseases and other ... / RxPG NEWS,
Spectrum Pharmaceuticals Announces the Hiring of Dr. Rudi E. ... -- Mar 14, 2005 ...endometriosis. Elsamitrucin, a phase 2 drug, is being studied for its initial indication, refractory non-Hodgkin's lymphoma. RenaZorb ... / PharmaLive.com (press release),
FDA weighing warning on cosmetics -- Mar 14, 2005 ...skin cancer. Hair dye, which can contain coal tar, which has been linked to bladder cancer and non-Hodgkin's lymphoma. "The bottom ... / philly.com,
Down memory lane -- Mar 14, 2005 And so when he lost his battle with non-Hodgkin's lymphoma in 2000 at the age of 16, everyone who knew him decided there was no better way to honor his memory ... / Centre Daily Times,
Heaven sent -- Mar 14, 2005 ...ill or dying child. When her son Mark was 11, he was diagnosed as having cancer, specifically non-Hodgkin's lymphoma. "We were at ... / Times Picayune,
Hepatitis C Raises Lymphoma, Bone Marrow Cancer -- Feb 23, 2005 Hepatitis C (search) infection increases a person's risk of non-Hodgkin's lymphoma (search) and multiple myeloma (search), a Swedish study suggests. ... / FOX News
Hereditary Cancer Expert Links Colorectal Cancer and Jewish People -- Mar 13, 2005 Furthermore, marked clinical examples found Jewish people also have a higher risk of cancer of the ovary, pancreas, stomach and non-Hodgkin's lymphoma. ... / I-Newswire.com (press release)
Dancing For Her Life: Bev Brown Fights Cancer With the Help of ... -- Mar 4, 2005 ...news. Ironically, a car accident saved her life as doctors in the emergency room found Non-Hodgkin's Lymphoma all over her body. ... / Chronicle - Hempstead (subscription),
Tests shows high levels of dioxin -- Mar 9, 2005 ...that have been linked with historical dioxin exposure (lymphocytic leukaemia, soft tissue sarcoma, Hodgkin's disease and non-Hodgkin's lymphoma) is expected to ... / TVNZ,
Higher dioxin level may indicate extra cancer risk - MOH -- Mar 9, 2005 ...that had been linked with historical dioxin exposure (lymphocytic leukaemia, soft tissue sarcoma, Hodgkin's disease and non-Hodgkin's lymphoma) was expected to ... / Stuff.co.nz,
| |